Added to YB: 2025-04-16
Pitch date: 2025-04-13
HIMS [neutral]
Hims & Hers Health, Inc.
+29.56%
current return
Author Info
Capitalist Letters simplifies investing and makes it understandable for everybody. Sign up for the newsletter.
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$8.9B
Pitch Price
$28.72
Price Target
N/A
Dividend
N/A
EV/EBITDA
52.94
P/E
73.02
EV/Sales
4.26
Sector
Health Care Providers and Services
Category
growth
Our Shopping List of Tariff Proof Stocks! - Hims & Hers Health, Inc.
HIMS (buy at $22): DTC telehealth leader, 77% 5-yr rev CAGR, 8.5% profit margin, 30% ROE. 50%+ subscribers on personalized plans. Acquired peptide facility to produce own ingredients (Semaglutide, weight-loss, T-boosters) insulating from tariff impact while competitors struggle. $26/$22 buy zones, adding at $22.
Read full article (1 min)